Related Experiment Video

Updated: Apr 15, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Molecular therapy for gastric cancer

Yasuhide Yamada1

  • 1Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. yayamada@ncc.go.jp.

Chinese Clinical Oncology
|April 6, 2015
PubMed

Insights

Targeted therapies, like anti-HER2 antibody, show promise for HER2-positive gastric cancer. Further translational research is needed to identify new targets and drugs for personalized gastric cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Translational Research

Background:

  • Gastric cancer treatment has explored molecularly targeted agents.
  • Anti-HER2 antibody combined with chemotherapy improves survival in HER2-positive gastric cancer.
  • This represents a successful targeted therapy for gastric cancer.

Purpose of the Study:

  • To review the success of targeted agents in gastric cancer.
  • To highlight the need for identifying new molecular targets.
  • To emphasize the development of personalized medicine approaches and novel drug candidates for gastric cancer.

Main Methods:

  • Review of preclinical and clinical studies on targeted agents for gastric cancer.
  • Analysis of the efficacy of anti-HER2 antibody in HER2-positive gastric cancer.
  • Discussion on translational research strategies for drug discovery.

Main Results:

  • Anti-HER2 antibody offers significant survival benefits in HER2-positive gastric cancer patients.
  • Targeted therapy is the only successful approach currently shown for gastric cancer treatment.
  • The success of anti-HER2 antibody validates targeted therapy strategies.

Conclusions:

  • Translational research is crucial for discovering specific molecular targets in gastric cancer.
  • Development of precise diagnostics is essential for personalized gastric cancer medicine.
  • Identifying novel drug candidates is a key future direction for gastric cancer therapy.
Keywords:
Gastric cancerHER2-positive gastric canceranti-HER2 antibodymolecular therapy

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K